ABC Transporters in Inflammation and Lipid Homeostasis
炎症和脂质稳态中的 ABC 转运蛋白
基本信息
- 批准号:7647664
- 负责人:
- 金额:$ 43.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:ABCG2 geneATP-Binding Cassette TransportersAddressAdoptive TransferAffectApolipoprotein EApoptosisApoptoticArterial Fatty StreakArteriesArtsAtherosclerosisAttenuatedBiological AssayBiotinylationBloodBone Marrow TransplantationCell LineCell surfaceCellsCholesterolCytoplasmic TailDataDevelopmentDiseaseEndoplasmic ReticulumEngineeringEventFigs - dietaryFluorescenceGene ExpressionGene ProteinsGene TargetingGenesHomeostasisIn VitroInflammationInflammatoryInflammatory ResponseKnockout MiceLeadLesionLifeLipidsLipoproteinsLungMetabolismMicroscopyMovementMusMutationMyocardial InfarctionPathway interactionsPhospholipidsPhysiologicalPredispositionPrimary Cell CulturesProcessProductionProteinsPublishingReportingResearch PersonnelRoleSterolsSurfaceT-Cell ProliferationT-LymphocyteTestingVesicleattenuationbasecell typegene inductionin vitro Assayin vivoinsightmacrophagemouse modelnoveloxidized lipidprogramsresponsesterol homeostasis
项目摘要
During the current grant period we characterized a number of LXR target genes including Abcgl, that is
thought to function as a sterol transmembrane transporter. Abcgl was shown to be expressed at high levels,
in a number of cell types including macrophages, B and T cells. We used cultured cells and Abcgl-/- mice to
demonstrate that ABCG1 functions to flux sterols away from the endoplasmic reticulum to exogenous sterol
acceptors, such as HDL. Loss of ABCG1 was associated with massive lipid accumulation, cytokine
activation, inflammation and an increase in IgM-secreting B-1 cells. Importantly, bone marrow
transplantation (BMT) studies identified a role for ABCG1 in the development of atherosclerosis. In
collaboration with Project 6 we also demonstrated an unexpected and novel role for ABCG1 in T cell
proliferation. We now propose to use two new mouse models, Abcgl-/-apoE-/- and Abcgl-/-Rag-/- double
knockout mice: i) to test the hypothesis that loss of ABCG1 attenuates the development of atherosclerosis as
a result of increased apoptosis, and to then identify the apoptotic pathway/mechanism involved, ii) to test the
hypothesis that loss of ABCG1 from B and T cells (and possibly B-1 cells) also affects atherosclerosis. The
latter studies will utilize adoptive transfer of B and T cells into Abcgl-/-RAG-/- mice followed by BMT into
Ldlr-/- recipient mice. In preliminary studies we have identified multiple oxysterols that accumulate in Abcgl-
/- macrophages in vivo. We now propose to better characterize the lipids and oxysterols that accumulate and
then determine the mechanism by which these specific oxysterols/lipids promote apoptosis both in vivo and
in vitro and induce massive cytokine expression, especially in macrophages lacking ABCGL We will also
use state-of-the-art spinning disc microscopy and fluorescent-tagged wild type or mutant ABCG1 to follow
intracellular movement of the transporter as a means of understanding how ABCG1 functions to flux sterols
through intracellular vesicles to the cell surface. Finally, we will use a new cell-based assay to test the
hypothesis that ABCG1, but but not ABCA1, functions to promote the efflux of specific sterols away from the
endoplasmic reticulum.
在当前赠款期间,我们表征了许多LXR靶基因,包括ABCGL,即
被认为充当固醇跨膜转运蛋白。显示ABCGL以高水平表示
在许多细胞类型中,包括巨噬细胞,B和T细胞。我们使用培养的细胞和ABCGL - / - 小鼠
证明ABCG1可从内质网向外源性固醇发挥作用。
受体,例如HDL。 ABCG1的损失与大量脂质积累,细胞因子有关
激活,炎症和分泌B-1细胞的增加。重要的是,骨髓
移植(BMT)研究确定了ABCG1在动脉粥样硬化发展中的作用。在
与项目6合作,我们还展示了ABCG1在T细胞中的意外和新颖的作用
增殖。我们现在建议使用两种新的鼠标型号ABCGL - / - APOE-/ - 和ABCGL - / - rag - / - double
敲除小鼠:i)检验以下假设:ABCG1的丧失会减弱动脉粥样硬化的发展
凋亡增加的结果,然后确定涉及的凋亡途径/机制,ii)测试
假设B和T细胞(以及可能的B-1细胞)丧失ABCG1也会影响动脉粥样硬化。这
后者的研究将利用B和T细胞的继发性转移到ABCGL - / - 抹布 - / - 小鼠,然后BMT进入
LDLR - / - 接收者小鼠。在初步研究中,我们已经确定了在ABCGL-中积累的多种氧
/ - 体内巨噬细胞。现在,我们建议更好地表征积累的脂质和氧
然后确定这些特定的氧化醇/脂质在体内促进凋亡的机制
体外并诱导大量的细胞因子表达,尤其是在缺乏ABCGL的巨噬细胞中,我们还将
使用最先进的旋转盘显微镜和荧光标记的野生型或突变体ABCG1遵循
转运蛋白的细胞内运动是一种理解ABCG1如何发挥通量固醇的手段
通过细胞内囊泡进入细胞表面。最后,我们将使用新的基于单元的基于细胞的分析来测试
假设ABCG1,但没有ABCA1的作用,可以促进特定固醇的外排。
内质网。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter A Edwards其他文献
Focal middle cerebral artery ischemia in rats via a transfemoral approach using a custom designed microwire
使用定制设计的微丝通过股动脉途径实现大鼠局灶性大脑中动脉缺血
- DOI:
10.1136/neurintsurg-2014-011607 - 发表时间:
2015 - 期刊:
- 影响因子:4.8
- 作者:
A. Divani;Ricky Chow;H. Sadeghi;Amanda J Murphy;J. Nordberg;Julian V. Tokarev;M. Hevesi;Xiao Wang;Xiao;Tommy Acompanado;Peter A Edwards;Yi Zhang;Wei Chen - 通讯作者:
Wei Chen
Peter A Edwards的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter A Edwards', 18)}}的其他基金
Novel FXR-dependent Molecular Mechanisms in the Regulation of Liver Metabolism
肝脏代谢调节中 FXR 依赖性新分子机制
- 批准号:
9889118 - 财政年份:2019
- 资助金额:
$ 43.21万 - 项目类别:
Novel FXR-dependent Molecular Mechanisms in the Regulation of Liver Metabolism
肝脏代谢调节中 FXR 依赖性新分子机制
- 批准号:
10320000 - 财政年份:2019
- 资助金额:
$ 43.21万 - 项目类别:
Novel transcriptional regulators of bile acid metabolism and hepatotoxicity
胆汁酸代谢和肝毒性的新型转录调节因子
- 批准号:
8670488 - 财政年份:2014
- 资助金额:
$ 43.21万 - 项目类别:
Novel transcriptional regulators of bile acid metabolism and hepatotoxicity
胆汁酸代谢和肝毒性的新型转录调节因子
- 批准号:
8811942 - 财政年份:2014
- 资助金额:
$ 43.21万 - 项目类别:
REGULATION OF MEVALONIC ACID AND CHOLESTEROL METABOLISM
甲羟戊酸和胆固醇代谢的调节
- 批准号:
6644320 - 财政年份:2002
- 资助金额:
$ 43.21万 - 项目类别:
相似国自然基金
基于超声多模态评价技术探讨肝脏靶向递送ABCA1新策略在动脉粥样硬化防治中的应用
- 批准号:81871357
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
基于SIRT1-LXR通路的化合物E4023抗动脉粥样硬化的作用及机制研究
- 批准号:81703503
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
基于LXRα-SREBP1-ABCA1/G1信号通路的益气活血化痰方调脂抗动脉粥样硬化机制研究
- 批准号:81774088
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
肝脏X受体激动剂干预β淀粉样蛋白诱导的视网膜炎性反应的作用及机制
- 批准号:81670881
- 批准年份:2016
- 资助金额:51.0 万元
- 项目类别:面上项目
新型ABCA1上调剂E17241改善糖脂代谢紊乱的机制研究
- 批准号:81573482
- 批准年份:2015
- 资助金额:50.0 万元
- 项目类别:面上项目
相似海外基金
Identification, Quantification, and Functional Characterization of Transporters in Human Placenta, Developing Gut and Fetal Brain
人胎盘、肠道和胎儿大脑发育中转运蛋白的鉴定、定量和功能表征
- 批准号:
10746192 - 财政年份:2023
- 资助金额:
$ 43.21万 - 项目类别:
Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome
解决胰腺癌和卵巢癌的化疗耐药性:使用靶向光激活多抑制剂脂质体进行四环素的光动力启动和再利用
- 批准号:
10197327 - 财政年份:2021
- 资助金额:
$ 43.21万 - 项目类别:
Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome
解决胰腺癌和卵巢癌的化疗耐药性:使用靶向光激活多抑制剂脂质体进行四环素的光动力启动和再利用
- 批准号:
10373082 - 财政年份:2021
- 资助金额:
$ 43.21万 - 项目类别:
Formulation of a targeted nanoparticle system for the treatment of chemoresistant breast cancer
用于治疗化疗耐药乳腺癌的靶向纳米颗粒系统的配制
- 批准号:
10472537 - 财政年份:2021
- 资助金额:
$ 43.21万 - 项目类别: